Eisai Co. Ltd. | Key People and Executives

Haruo Naito
Chief Executive Officer & Representative Director
Hirokazu Kanai
Director
Noboru Naoe
Director
Nobuo Deguchi
Director
Daiken Tsunoda
Independent Director
Tamaki Kakizaki
Independent Director
Yasuhiko Katoh
Independent Director
Eiichiro Suhara
Independent Director
Ikuo Nishikawa
Independent Director
Toru Yamashita
Independent Director
Graham Fry
Independent Director
Haruo Naito
Chief Executive Officer & Representative Director
Ryohei Yanagi
Chief Financial Officer & Chief IR Officer
Hideki Hayashi
Chief Information Officer
Masatomi Akana
Vice President-Corporate Affairs
Teiji Kimura
VP & Chief Discovery Officer-Neurology Business Gp
Yasunobu Kai
Vice President
Ivan Cheung
Managing Executive Officer
Gary Hendler
Managing Executive Officer
Yuji Matsue
Managing Executive Officer
Takafumi Asano
Senior Managing Executive Officer
Yutaka Tsuchiya
Representative Executive Officer
Hideshi Honda
Representative Executive Officer
Edward Stewart Geary
Chief Medical Officer & Managing Executive Officer
Junichi Asatani
Chief Compliance Officer & Executive Officer
Lynn D. Kramer
Chief Clinical Officer & Chief Medical Officer
Terushige Iike
Chief Product Creation Officer
Takashi Owa
Chief Innovation Officer & Executive Officer
Hirokazu Kanai
Director
Noboru Naoe
Director
Nobuo Deguchi
Director
Yasushi Okada
General Manager-Human Resources Development
Kenta Takahashi
Managing Executive Officer & General Counsel
Daiken Tsunoda
Independent Director
Tamaki Kakizaki
Independent Director
Yasuhiko Katoh
Independent Director
Eiichiro Suhara
Independent Director
Ikuo Nishikawa
Independent Director
Toru Yamashita
Independent Director
Graham Fry
Independent Director

About Eisai Co.

View Profile
Address
4-6-10 Koishikawa
Tokyo Tokyo 112
Japan
Employees -
Website http://www.eisai.co.jp
Updated 07/08/2019
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs.